HomeOpen Access NewsInfection Control

Infection Control

Scientists reveal new vaccine for recurring yeast infections

University of Georgia researchers have successfully created a vaccine that protects and treats vaginal yeast infections in mice.

Pfizer-BioNTech vaccine to be offered to 16-17-year-olds

The Joint Committee on Vaccination and Immunisation (JCVI) has recommended that all 16 and 17-year-olds should receive their first dose of the Pfizer-BioNTech vaccine.

European commission approves contract for Novavax vaccine

The European Commission has approved a new contract that will allow Member States to purchase up to 100 million doses of the Novavax vaccine.

NHS Track and Trace app will ‘ping’ fewer contacts to isolate

Fewer contacts will be notified to self-isolate following updates to the NHS COVID-19 Track and Trace app.

Clinical trial to investigate vaccine dose interval for pregnant women

A new clinical trial, funded by the UK government, will investigate the best gap between the first and second COVID-19 vaccine dose for pregnant women.

£1.1 million given for Long Covid research

A new research project, known as LISTEN, has been awarded £1.1 million of UK government funding to support people with Long Covid.

UK donates 9 million AstraZeneca vaccines to countries overseas

The UK will begin to deliver 9 million AstraZeneca COVID-19 vaccines around the world this week, announces Foreign Secretary Dominic Raab.

More than 10 million people have signed up to use the NHS App

Over 6 million more people have signed up to the NHS App since the COVID-19 vaccination status service, bringing its total number of users to more than 10 million.

Study highlights importance of second COVID-19 vaccine

Findings from a new study strongly emphasise why the second dose of the COVID-19 vaccine should not be skipped.

Flu jab will be freely available to more than 35 million people this winter

Health and Social Care Secretary Sajid Javid has announced that over 35 million people will have access to a free flu vaccine this winter.

Nearly 100% of people tested positive for antibodies after second vaccine

New data has found that nearly 100% of people tested positive for COVID-19 antibodies after their second dose of the Pfizer or AstraZeneca vaccine.

How games can be used to combat health and vaccine misinformation

Soraiya Verjee, Business Development Director of Sea Monster, discusses how the use of games and animation can combat COVID-19 and vaccine misinformation.

26% of COVID-19 patients still symptomatic after 6-8 months

According to a new study, by researchers at the University of Zurich, more than a quarter of COVID-19 patients report being symptomatic 6-8 months after infection.

Freedom Day could put us in another lockdown, says London Medical Laboratory

The London Medical Laboratory has voiced its concerns about Freedom Day as the Government's decision to end restrictions is based on the wrong data and could land us in another lockdown.

Fully vaccinated travellers will no longer have to quarantine from July 19

Fully vaccinated travellers returning to England from amber list countries will no longer need to quarantine from July 19th.

9 in 10 adults have COVID-19 antibodies, according to new survey

A new Government survey has found that 9 in 10 adults have COVID-19 antibodies, but experts say more data is needed before 'Freedom Day'.

Supporting vaccination campaigns through high-quality cold storage solutions

Arthur Goudena, Marketing Manager of PHC Europe, explains how the company’s cold storage solutions are available to support COVID-19 vaccination campaigns across Europe.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders